PortfoliosLab logoPortfoliosLab logo
DTIL vs. TGTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

DTIL vs. TGTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Precision BioSciences, Inc. (DTIL) and TG Therapeutics, Inc. (TGTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, DTIL achieves a 69.71% return, which is significantly higher than TGTX's 54.88% return.


DTIL

1D
1.00%
1M
-13.69%
6M
77.39%
YTD
69.71%
1Y
52.81%
3Y*
-25.10%
5Y*
-52.74%
10Y*
ALL TIME*
-44.57%

TGTX

1D
-11.26%
1M
-13.39%
6M
58.22%
YTD
54.88%
1Y
31.84%
3Y*
62.75%
5Y*
13.74%
10Y*
22.60%
ALL TIME*
-8.54%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$1.80M$3.69M$3.28M
$135.09M$122.10M$123.97M

DTIL vs. TGTX - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
DTIL
Precision BioSciences, Inc.
69.71%9.19%-65.21%-69.33%-83.92%-11.27%-39.96%-22.83%
TGTX
TG Therapeutics, Inc.
54.88%-0.96%76.23%44.38%-37.74%-63.48%368.65%53.74%

Correlation

The correlation between DTIL and TGTX is 0.26, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.26

Correlation (3Y)
Balances recent behavior with more history.

0.24

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.36

Correlation (All Time)
Calculated using the full available price history since Mar 28, 2019

0.35

The correlation between DTIL and TGTX shifts across timeframes, from 0.24 (3 years) to 0.36 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

DTIL:

$90.57M

TGTX:

$7.07B

EPS

DTIL:

-$2.71

TGTX:

$2.88

PS Ratio

DTIL:

2.57

TGTX:

10.56

PB Ratio

DTIL:

2.29

TGTX:

12.67

Total Revenue (TTM)

DTIL:

$45.07M

TGTX:

$700.35M

Gross Profit (TTM)

DTIL:

$32.19M

TGTX:

$581.54M

EBITDA (TTM)

DTIL:

-$30.02M

TGTX:

$156.88M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DTIL vs. TGTX — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

DTIL
DTIL Risk / Return Rank: 6666
Overall Rank
DTIL Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
DTIL Sortino Ratio Rank: 6868
Sortino Ratio Rank
DTIL Omega Ratio Rank: 6666
Omega Ratio Rank
DTIL Calmar Ratio Rank: 6464
Calmar Ratio Rank
DTIL Martin Ratio Rank: 6262
Martin Ratio Rank

TGTX
TGTX Risk / Return Rank: 6666
Overall Rank
TGTX Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
TGTX Sortino Ratio Rank: 6464
Sortino Ratio Rank
TGTX Omega Ratio Rank: 6464
Omega Ratio Rank
TGTX Calmar Ratio Rank: 6969
Calmar Ratio Rank
TGTX Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

DTIL vs. TGTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Precision BioSciences, Inc. (DTIL) and TG Therapeutics, Inc. (TGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


DTILTGTXDifference
Sharpe ratioReturn per unit of total volatility

+0.10

Sortino ratioReturn per unit of downside risk

+0.23

Omega ratioGain probability vs. loss probability

1.17

1.16

+0.01

Calmar ratioReturn relative to maximum drawdown

0.91

1.19

-0.28

Martin ratioReturn relative to average drawdown

1.72

2.61

-0.90

DTIL vs. TGTX - Sharpe Ratio Comparison

The current DTIL Sharpe Ratio is 0.76, which is comparable to the TGTX Sharpe Ratio of 0.66. The chart below compares the historical Sharpe Ratios of DTIL and TGTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

DTIL vs. TGTX - Drawdown Comparison

The maximum DTIL drawdown since its inception was -99.39%, roughly equal to the maximum TGTX drawdown of -99.52%. Use the drawdown chart below to compare losses from any high point for DTIL and TGTX.


Loading charts...

Drawdown Indicators


DTILTGTXDifference

Max Drawdown

Largest peak-to-trough decline

-99.39%

-99.52%

+0.13%

Max Drawdown (1Y)

Largest decline over 1 year

-58.54%

-26.85%

-31.69%

Max Drawdown (3Y)

Largest decline over 3 years

-80.77%

-42.06%

-38.71%

Max Drawdown (5Y)

Largest decline over 5 years

-99.16%

-89.47%

-9.69%

Max Drawdown (10Y)

Largest decline over 10 years

-93.19%

Current Drawdown

Current decline from peak

-98.80%

-80.22%

-18.58%

Average Drawdown

Average peak-to-trough decline

-78.09%

-91.30%

+13.21%

Ulcer Index

Depth and duration of drawdowns from previous peaks

30.83%

13.55%

+17.28%

Volatility

DTIL vs. TGTX - Volatility Comparison

Precision BioSciences, Inc. (DTIL) has a higher volatility of 18.17% compared to TG Therapeutics, Inc. (TGTX) at 17.01%. This indicates that DTIL's price experiences larger fluctuations and is considered to be riskier than TGTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


DTILTGTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.17%

17.01%

+1.16%

Volatility (6M)

Calculated over the trailing 6-month period

51.62%

36.08%

+15.54%

Volatility (1Y)

Calculated over the trailing 1-year period

69.96%

48.61%

+21.35%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

79.90%

87.26%

-7.36%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

84.45%

86.79%

-2.34%

Dividends

DTIL vs. TGTX - Dividend Comparison

Neither DTIL nor TGTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

DTIL vs. TGTX - Financials Comparison

This section allows you to compare key financial metrics between Precision BioSciences, Inc. and TG Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


DTIL and TGTX have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

DTIL has higher volatility (18.17%) compared to TGTX (17.01%). In terms of maximum drawdown, DTIL dropped -99.39% vs TGTX's -99.52%.

DTIL currently has the higher Sharpe Ratio (0.76 vs 0.66), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for DTIL and TGTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer